Pre-application Meeting for Requests-for-Applications (RFAs) for the Early Detection Research Network (EDRN) (RFA-CA-09-017, CA-09-018, CA-09-019, and CA-09-020)

---

Notice Number: NOT-CA-09-033

Key Dates
Release Date: August 19, 2009

Issued by
National Cancer Institute (NCI), (http://www.nci.nih.gov/)

The NCI will hold a pre-application meeting for four Requests for Applications (RFAs) corresponding to the components of the NCI program for Early Detection Research Network (EDRN). These EDRN components are as follows:

1. Biomarker Developmental Laboratories (covered by RFA-CA-09-017);
2. Clinical Validation Centers (covered by RFA-CA-09-018)
3. Biomarker Reference Laboratories (covered by RFA-CA-09-019); and
4. Data Management and Coordinating Center and Statistical and Biomarker Resource Center (covered by RFA-CA-09-020)

All prospective applicants are invited to attend this meeting. This meeting will take place in Masur Auditorium (Building 10) on the main campus of National Institutes of Health (NIH) in Bethesda, MD from1:00 pm to 4:00 pm on September 29, 2009.

The meeting is intended to be informative to prospective applicants considering responding to the EDRN RFAs. NCI Program Staff and other NCI representatives will provide an overview of the EDRN program and will explain specific aspects of each of the four RFAs. ,A short presentation will be followed by a question and answers session.

Questions prior to and during the meeting may be submitted by e-mail to [email protected] .
This meeting is open to the public and will be available via web cast at http://videocast.nih.gov. An archived recording of the web cast will be available after the meeting at http://videocast.nih.gov/pastevents.asp.


Participation in the meeting, although encouraged, is optional and not required for application submission. Please be advised that the NCI does not cover your expenses to attend this meeting.

Note: Prospective applicants interested in attending this meeting in person are asked to provide in advance (see contact below) the name of the attendee, the name of the applicant/Principal Investigator for a possible or planned application, institutional affiliation, address, e-mail address, telephone number, and fax number. This informal registration is optional and is primarily for planning purposes.

Inquiries

For information on the NIH campus, including directions and maps, please see: http://www.nih.gov/about/visitor/index.htm

If you plan to attend this meeting or have any questions, please contact

Sudhir Srivastava, Ph.D., M.P.H.
Program Coordinator
Division of Cancer Prevention
National Cancer Institute
6130 Executive Boulevard, EPN Room 3142
Bethesda, MD 20892-7362
Telephone: (301) 435-1594
FAX: (301) 402-8990
Email: [email protected]

---

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

---